Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

231 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Active, Not Recruiting

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

NCT05058404

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia Meldola, Forlì - Cesena, Italy
  • U.O.C. Ematologia Ospedale Civile di Legnano Legnano, Milano, Italy
  • Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico Sassuolo, Modena, Italy
  • ASST MONZA Ospedale S. Gerardo - Ematologia Monza, Monza E Brianza, Italy
View all 54 locations
View Trial Details
Active, Not Recruiting

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

NCT06070961

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +32 more
Locations
  • Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, AV, Italy
  • A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia Alessandria, IT, Italy
  • Nuovo Ospedale degli Infermi, SSD Ematologia Biella, IT, Italy
  • ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia Milan, IT, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma

NCT04246086

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Norton Cancer Institute - St. Matthews Louisville, Kentucky, United States
  • Mary Bird Perkins Cancer Ctr Baton Rouge, Louisiana, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

NCT04594642

Conditions
B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +13 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site New Brunswick, New Jersey, United States
  • Research Site Charlotte, North Carolina, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

NCT04468841

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
  • Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
  • University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
View Trial Details

Related conditions